Impact of pretransplant minimal residual disease after cord blood transplantation for childhood acute lymphoblastic leukemia in remission: an Eurocord, PDWP–EBMT analysisAnnalisa Ruggeri, Vanderson Rocha, Nabil Kabbara et al.|Leukemia|2012Cited by 50
Haploidentical transplantation in high‐risk pediatric leukemia: A retrospective comparative analysis on behalf of the Spanish working Group for bone marrow transplantation in children (GETMON) and the Spanish Grupo for hematopoietic transplantation (GETH)Antonio Pérez‐Martínez, Miguel Ángel Díaz, Cristina Ferreras et al.|American Journal of Hematology|2019Cited by 46
Haploidentical transplantation in pediatric non‐malignant diseases: A retrospective analysis on behalf of the Spanish Group for Hematopoietic Transplantation (GETH)Juan Manuel Torres, Antonio Pérez‐Martínez, Cristina Ferreras et al.|European Journal Of Haematology|2020Cited by 16
Haploidentical hematopoietic stem cell transplantation in pediatric and adolescent patients: A study of the Spanish hematopoietic stem cell transplantation group (GETH)Bárbara Ochoa-Fernández, Antonio Pérez‐Martínez, Víctor Galán‐Gómez et al.|Medicina Clínica|2022Cited by 4
Aplasia medular grave adquirida: evolución histórica de los resultados obtenidos con trasplante de progenitores hematopoyéticos de donante familiar. Estudio del Grupo Español para el Trasplante de Médula Ósea en Niños (GETMON)Arturo Muñoz Villa, María Soledad Maldonado Regalado, Cristina Díaz de Heredia et al.|Anales de Pediatría|2008Cited by 3